10 results
424B5
ACST
Acasti Pharma Inc - Ordinary Shares
14 Feb 19
Prospectus supplement for primary offering
8:06am
for the commercialization of CaPre in certain Asian countries; and
our expectation regarding our financial performance, including our revenues … CaPre in certain Asian countries, and it is possible that no definitive agreement with the China-based company will be reached, or if a definitive
POS AM
ACST
Acasti Pharma Inc - Ordinary Shares
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
a definitive agreement based upon a non-binding term sheet with a China-based pharmaceutical company for the commercialization of CaPre in certain Asian
424B5
j1gw hcnocob91721
5 Oct 18
Prospectus supplement for primary offering
12:00am
424B5
f7e89k2ci7ax
3 Oct 18
Prospectus supplement for primary offering
4:51pm
6-K
EX-99.1
0y44p0o
14 Aug 18
Current report (foreign)
7:00am
6-K
EX-99.1
vjgx6
27 Jun 18
Current report (foreign)
5:27pm
- Prev
- 1
- Next